The keywords that can be used in searching the main scientific literature on the issue are ‘ER+ advanced/metastatic breast cancer’, ‘cytokines’, ‘immunotherapy’, ‘cyclin kinase 4/6 inhibitors’, ‘TILs’ ‘cancer immunity cycle’ and ‘anti-tumour immune response’. Here, ESR1 is linked to breast carcinoma.